BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population

Aim To investigate the associations of low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) with metabolic dysfunction-associated fatty liver disease (MAFLD), with a specific focus on the effect modification by body mass index (BMI) and the unique role of TG. Methods This cross-sectional study included 7035 participants who underwent FibroTouch examinations. Multivariable logistic regression, restricted cubic splines, subgroup analyses, additive interaction analyses, and ROC curves were used to assess the associations between lipid parameters and MAFLD. Results Elevated LDL-C, non-HDL-C, and TG were positively associated with MAFLD, while HDL-C was negatively associated (all p < 0.001). All lipid-MAFLD associations were significantly modified by BMI (all P for interaction < 0.001), with stronger associations in non-overweight individuals. Only TG showed a significant synergistic effect with high BMI (RERI = 12.99, 95% CI: 7.59–19.84) and had the highest AUC (AUC = 0.759). However, no lipid parameters were independently associated with significant liver fibrosis. Conclusion In this hospital-based population undergoing metabolic-liver assessment, the associations between lipid parameters and MAFLD were universally modified by BMI, with stronger associations observed in non-overweight individuals. TG may play a unique dual role: it appeared to be the strongest correlate of MAFLD among lipid parameters in non-overweight individuals, showed a synergistic effect with BMI in overweight/obese individuals, and had the highest AUC among single lipid parameters for MAFLD. In clinical practice, hypertriglyceridemia in non-overweight individuals may warrant attention, and the combined effect of high TG and high BMI in overweight/obese individuals could be recognized.

Authors

Institutions

Publication Details

Journal
Frontiers in Physiology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphys.2026.1923243
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population

Zhengming Li, Xiaoying Chen, Ruibing Qi, Jiaqin Jiang et al.
4 links
Frontiers in Physiology
Liver Disease Diagnosis and Treatment
article

BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population

Zhengming Li, Xiaoying Chen, Ruibing Qi, Jiaqin Jiang, Xingye Wu, Shisi Zhang, Jinming Yu
article en

Abstract

Aim To investigate the associations of low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) with metabolic dysfunction-associated fatty liver disease (MAFLD), with a specific focus on the effect modification by body mass index (BMI) and the unique role of TG. Methods This cross-sectional study included 7035 participants who underwent FibroTouch examinations. Multivariable logistic regression, restricted cubic splines, subgroup analyses, additive interaction analyses, and ROC curves were used to assess the associations between lipid parameters and MAFLD. Results Elevated LDL-C, non-HDL-C, and TG were positively associated with MAFLD, while HDL-C was negatively associated (all p < 0.001). All lipid-MAFLD associations were significantly modified by BMI (all P for interaction < 0.001), with stronger associations in non-overweight individuals. Only TG showed a significant synergistic effect with high BMI (RERI = 12.99, 95% CI: 7.59–19.84) and had the highest AUC (AUC = 0.759). However, no lipid parameters were independently associated with significant liver fibrosis. Conclusion In this hospital-based population undergoing metabolic-liver assessment, the associations between lipid parameters and MAFLD were universally modified by BMI, with stronger associations observed in non-overweight individuals. TG may play a unique dual role: it appeared to be the strongest correlate of MAFLD among lipid parameters in non-overweight individuals, showed a synergistic effect with BMI in overweight/obese individuals, and had the highest AUC among single lipid parameters for MAFLD. In clinical practice, hypertriglyceridemia in non-overweight individuals may warrant attention, and the combined effect of high TG and high BMI in overweight/obese individuals could be recognized.

Frontiers in PhysiologyVol. 17
The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon